Well, 2024 departs as the ghost of Christmas past. It leaves the US stock market posting stellar gains, especially in tech. Nividia and...

The tech bonanza up to 2022 is well behind us as war in Europe, interest rates in the US and geopolitical tensions around oil,...

DON'T BRING A KNIFE TO A GUNFIGHT Grateful for Covid vaccines as someone vaccinated before infection. Christmas for the Shanahan's -...

Leaving Covidium This past two years we have all been inhabiting "Covidium"- a bleak land of Corono virus and variants, blighted by...

Bill Murray's Groundhog day started with the main character reliving the same day over and over if I recall...its a forgettable film so I...

This picture of a beautiful Baptist church in Co Kildare, Ireland, where I live reminds me of better days ahead. As science, pharma...

Well this year will live long in the memory... Covid19 has transformed every aspect of our lives and our ideas about work, our...

Tomorrow the US electorate goes to the polls, aside from some 90 or so million who have already cast and mailed their ballots. This is a...

Protecting against SARS-CoV-2. "Simplicity is the Ultimate Sophistication" - (Da Vinci). An essay (if you will), from someone with dearly...

Its always hard at the beginning of a year to imagine how it may go. I've been an inveterate annual planner for many years and I often...

Its hard to think of a year in recent times where one has the feeling of standing on the cusp of history. Two defining and largely...

Today the FDA announced they will invite submission on the treatment of digital supports to patients such as APP's, dose calculators and...

It's been too busy to update blogs regularly. I note my last blog was almost 6 months ago! Since then Mr Trump has presided over chaos,...

As we get ready for new year's resolutions, its timely to reflect on 2017 ...just a little and on not a lot. The world is too sad and too...

In my last post almost 8 months ago I imagined US president Donald Trump would follow up on his rhetoric and begin the shake-up of the US...

One must have pity for Valeant shareholders who have seen their previous wealth at $250 per share in August 2015 drop to $65 dollars per...

As anticipated given the PE ratio's of companies in the DOW, troubles in China coupled with rising concerns about the strength of the...

Recent blogs have focused on US Pharma Pricing practices. Since Turing Pharmaceuticals gouged the US market with astronomical price hikes...

One of the characteristics of America's healthcare system is its adaptability to innovation and of course its focus on securing greater...

Fierce Pharma reports that Valeant's recent US price hikes which garnered negative publicity for two medicines are not isolated. "The...